Zoetis Eyes Growth Amid Low Market Expectations
Zoetis seeks to outperform low market expectations for late 2026 by leveraging parasite prevention and livestock sector resilience.
Zoetis is working to reverse a period of stock underperformance as it enters the third and fourth quarters of 2026. Current market consensus and management guidance anticipate declines in both revenue and earnings per share for the remainder of the year.
Despite these low expectations, the company is utilizing diversified growth levers to potentially beat financial forecasts. These drivers include the expansion of parasite prevention products and resilient sales within the livestock sector.
Additionally, the company is focusing on the development of its diagnostics business as a long-term growth engine to stabilize its market position.
